Modern approach in treatment of diabetes insipidus
- PMID: 16053453
- PMCID: PMC7214070
- DOI: 10.17305/bjbms.2005.3282
Modern approach in treatment of diabetes insipidus
Abstract
In this paper we have reviewed the position of desmopressin in the treatment of diabetes insipidus. Desmopressin is a synthetic analog of vasopressin, with more pronounced antidiuretic effect. It is treatment of choice in substitution therapy of diabetes insipidus. Its application before sleeping time can reduce nocturnal enuresis, so it has a place in the treatment of enuresis nocturna. Antidiuretic effect of desmopressin is the result of agonistic effect on V2 receptors in the renal tubules. The efficacy and safety of desmopressin in mentioned indications was confirmed in clinical studies.
Similar articles
-
Desmopressin (DDAVP) for enuresis, diabetes insipidus, and..Urol Nurs. 2004 Dec;24(6):520-3. Urol Nurs. 2004. PMID: 15658741 No abstract available.
-
Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions.J Pediatr. 1989 Apr;114(4 Pt 2):711-8. doi: 10.1016/s0022-3476(89)80886-8. J Pediatr. 1989. PMID: 2647953 Review.
-
Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus.Lancet. 2002 Feb 9;359(9305):495-7. doi: 10.1016/S0140-6736(02)07667-5. Lancet. 2002. PMID: 11853799
-
Desmopressin for diabetes insipidus, hemostatic disorders and enuresis.Am Fam Physician. 1990 Oct;42(4):1051-7. Am Fam Physician. 1990. PMID: 2220513 Review.
-
[Diabetes insipidus: approaches to desmopressin substitution therapy].Klin Med (Mosk). 2011;89(4):30-3. Klin Med (Mosk). 2011. PMID: 21932559 Russian.
Cited by
-
3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidus.MAGMA. 2014 Feb;27(1):47-52. doi: 10.1007/s10334-013-0377-4. Epub 2013 Apr 6. MAGMA. 2014. PMID: 23563855
-
dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells.Front Cell Dev Biol. 2022 Jul 8;10:919438. doi: 10.3389/fcell.2022.919438. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35874817 Free PMC article.
References
-
- MICROMEDEX*(2005) Copyright Micromedex Inc. 1974/2005. Micromedex*Healthcare Series 2005;123.3. Drugdex Drug Evaluation:LYPRESSIN
-
- Lethagen S, Flordal P, Van Aken H, et al. The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Eur J Anaesthesiol. 1997;14(14):19–22. - PubMed
-
- PDR. Physicians'Desk Reference, 57 Edition, 2003, Copyright 2003 and published by Thomson PDR at Montvale, NJ, 732734. 2003
-
- Hunsballe J.M, Hansen T.K, Rittig S, et al. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis. Clin Endocrinol (Oxf) 1998;49(6):793–801. - PubMed
-
- Takahashi-Tezuka M, Kobayashi J, Otabe M, et al. A clinical feature of hyperlipidemia in patients with central diabetes insipidus. Endocr J. 2000;47:557–562. - PubMed